Surgery for Endocrinological Diseases and Malformations in Childhood

Endocrine conditions requiring surgical intervention in the pediatric age­ group are uncommon. When diagnosed, they are the source of great in­ terest and, often, considerable debate. This is understandable, since few centers and even fewer individual surgeons can draw on vast experience of this sub...

Full description

Bibliographic Details
Other Authors: Gauderer, Michael W.L. (Editor), Angerpointner, Thomas A. (Editor)
Format: eBook
Language:English
Published: Berlin, Heidelberg Springer Berlin Heidelberg 1991, 1991
Edition:1st ed. 1991
Series:Progress in Pediatric Surgery
Subjects:
Online Access:
Collection: Springer Book Archives -2004 - Collection details see MPG.ReNa
LEADER 03773nmm a2200313 u 4500
001 EB000678756
003 EBX01000000000000000531838
005 00000000000000.0
007 cr|||||||||||||||||||||
008 140122 ||| eng
020 |a 9783642883248 
100 1 |a Gauderer, Michael W.L.  |e [editor] 
245 0 0 |a Surgery for Endocrinological Diseases and Malformations in Childhood  |h Elektronische Ressource  |c edited by Michael W.L. Gauderer, Thomas A. Angerpointner 
250 |a 1st ed. 1991 
260 |a Berlin, Heidelberg  |b Springer Berlin Heidelberg  |c 1991, 1991 
300 |a X, 144 p. 48 illus  |b online resource 
505 0 |a Sonographic Imaging of the Thyroid in Children -- Surgical Aspects of Diseases of the Thyroid Gland in Childhood -- Surgery for Benign and Malignant Diseases of the Thyroid Gland in Childhood -- Indications, Surgical Treatment and After-Care in Juvenile Hyperthyroidism -- Late Results of Thyroid Surgery for Hyperthyroidism Performed in Childhood -- Late Prognosis of Childhood and Juvenile Thyroid Carcinomas -- Parathyroid Surgery in Children -- Current Status of Pancreatectomy for Persistent Idiopathic Neonatal Hypoglycemia Due to Islet Cell Dysplasia -- Surgery for Nesidioblastosis — Indications, Treatment and Results -- Surgical Treatment of Nesidioblastosis in Childhood -- Total Pancreatectomy in a Case of Nesidioblastosis Due to Persisting Hyperinsulinism Following Subtotal Pancreatectomy -- Pancreatic Head Tumor in a Child -- Pheochromocytoma in Childhood -- Surgical Treatment of Ovarian Tumors in Childhood -- Recent Developments in the Management of Neuroblastoma 
653 |a Children / Surgery 
653 |a Endocrinology 
653 |a Pediatric Surgery 
653 |a Pediatrics 
700 1 |a Angerpointner, Thomas A.  |e [editor] 
041 0 7 |a eng  |2 ISO 639-2 
989 |b SBA  |a Springer Book Archives -2004 
490 0 |a Progress in Pediatric Surgery 
028 5 0 |a 10.1007/978-3-642-88324-8 
856 4 0 |u https://doi.org/10.1007/978-3-642-88324-8?nosfx=y  |x Verlag  |3 Volltext 
082 0 |a 617.98 
520 |a Endocrine conditions requiring surgical intervention in the pediatric age­ group are uncommon. When diagnosed, they are the source of great in­ terest and, often, considerable debate. This is understandable, since few centers and even fewer individual surgeons can draw on vast experience of this subject. The great divergence of opinion regarding management is also understandable in that pediatric endocrine lesions often differ considerably from their adult counterparts in histology, natural history and response to treatment. Pediatric endocrine lesions are also, as a rule, less frequently malignant. In addition to the great strides made in surgical and anesthetic technique and operative monitoring, progress in four areas has substantially advanced the management of endocrine dis­ orders in the pediatric age group in the last decade: imaging, pathology, pharmacology and genetics. The new imaging tools, ultrasonography, computed tomography and magnetic resonance imaging, have added great diagnostic possibilities. More recent developments, such as radio nuclide imaging for the adrenal gland and the possibility of using tagged antibodies, promise to expand our imaging horizons even further. In the field of pathology, the develop­ ment of immunocytochemical markers (e. g. , monoclonal antibodies), the refinement in special stains and the continuous perfection of fine needle aspiration biopsies offer great new diagnostic as well as research capabil­ ities. Newer pharmacological agents, such as the alpha and beta blockers, the calcium channel blockers and thyroxine analogs, add a whole new level of safety to the management of the potentially lethal pheochromocytoma